Full Paper
802, 733, 647, 484, 430 cmÀ1
;
HRMS (ESI): m/z: calcd for
125.7, 136.6, 147.0, 147.1, 158.8, 199.8 ppm; IR: n˜ =3413, 3056,
C21H18BrNNaO2: 418.0419 [M+Na]+; found: 418.0417.
2961, 2869, 2247, 1674, 1575, 1496, 1359, 1218, 916, 824, 739, 605,
425 cmÀ1
; HRMS (ESI): m/z: calcd for C24H25NNaO2: 382.1783
1-[6-Bromo-2-methyl-4-(1-methyl-2-phenyl-1H-indol-3-yl)-4H-
chromen-3-yl]ethanone (3 f): Brown liquid; 1H NMR (400 MHz,
CDCl3, 258C, TMS): d=1.98 (s, 3H), 2.01 (s, 3H), 3.41 (s, 3H), 5.36 (s,
1H), 6.76 (d, J=8.0 Hz, 1H), 7.01 (d, J=4.0 Hz, 1H), 7.07 (s, 1H),
7.11–7.31 (m, 5H), 7.42 (s, 3H), 7.71 ppm (d, J=8.0 Hz, 1H);
13C NMR (100 MHz, CDCl3): d=19.2, 29.8, 30.3, 31.9, 109.5, 112.5,
116.9, 117.2, 118.2, 120.0, 121.8, 126.3, 126.7, 127.4, 128.2, 128.5,
128.6, 130.7, 131.5, 136.4, 138.9, 147.4, 155.7, 199.5 ppm; IR: n˜ =
3055, 2928, 2248, 1882, 1683, 1610, 1574, 1477, 1359, 1240, 1218,
908, 817, 735, 546 cmÀ1; HRMS (ESI): m/z: calcd for C27H22BrNNaO2:
494.0732 [M+Na]+; found: 494.0714.
[M+Na]+; found: 382.1775.
1-[4-(1H-Indol-3-yl)-2,8-dimethyl-4H-chromen-3-yl]ethanone (3l):
Brown liquid; 1H NMR (400 MHz, CDCl3, 258C, TMS): d=2.12 (s,
3H), 2.23 (s, 3H), 2.47 (s, 3H), 5.30 (s, 1H), 6.79–6.84 (m, 2H), 6.91
(d, J=7.2 Hz, 1H), 7.06–7.12 (m, 3H), 7.18–7.20 (m, 1H), 7.69–7.71
(m, 1H), 8.28 ppm (s, 1H); 13C NMR (100 MHz, CDCl3): d=15.3, 19.5,
29.1, 32.8, 111.0, 113.4, 118.2, 119.3, 121.0, 121.6, 122.6, 123.3,
124.5, 124.9, 125.3, 125.8, 128.3, 136.1, 147.0, 158.0, 199.7 ppm; IR:
n˜ =3412, 3346, 3055, 2922, 2247, 1676, 1578, 1467, 1378, 1247,
1197, 1091, 936, 909, 739, 649, 425 cmÀ1; HRMS (ESI): m/z: calcd for
C21H19NNaO2: 340.1313 [M+Na]+; found: 340.1305.
1-[6-Chloro-4-(1H-indol-3-yl)-2-methyl-4H-chromen-3-yl]etha-
1
none (3g): Brown liquid; H NMR (400 MHz, CDCl3, 258C, TMS): d=
1-[4-(1H-Indol-3-yl)-8-methoxy-2-methyl-4H-chromen-3-yl]etha-
none (3m): Brown liquid; 1H NMR (400 MHz, CDCl3, 258C, TMS):
d=2.15 (s, 3H), 2.50 (s, 3H), 3.87 (s, 3H), 5.32 (s, 1H), 6.67–6.69 (m,
1H), 6.84–6.86 (s, 2H), 6.93 (d, J=2.4 Hz, 3H), 7.12–7.14 (m, 2H),
7.25–7.27 (m, 1H), 7.70–7.72 (m, 1H), 8.27 ppm (s, 1H); 13C NMR
(100 MHz, CDCl3): d=19.8, 29.5, 33.0, 56.0, 109.6, 111.3, 113.8,
118.6, 119.8, 120.3, 121.3, 122.0, 122.6, 123.9, 125.7, 126.2, 136.4,
138.7, 147.5, 157.9, 199.7 ppm; IR: n˜ =3403, 3056, 2933, 2840,
2248, 1675, 1576, 1483, 1330, 1204, 1094, 910, 738, 646, 600,
2.13 (s, 3H), 2.42 (s, 3H), 5.27 (s, 1H), 6.91–6.93 (m, 2H), 7.03 (dd,
Ja =2.4, Jb =8.8 Hz, 1H), 7.10–7.16 (m, 3H), 7.26 (d, J=7.6 Hz, 1H),
7.62 (d, J=7.6 Hz, 1H), 8.36 ppm (s, 1H); 13C NMR (100 MHz,
CDCl3): d=19.7, 29.6, 33.0, 111.5, 113.5, 117.5, 118.4, 119.9, 120.4,
122.2, 122.6, 125.5, 126.6, 127.5, 128.5, 128.8, 136.5, 147.6, 157.7,
199.7 ppm; IR: n˜ = 3403, 3354, 3058, 2924, 2248, 1883, 1677, 1619,
1572, 1480, 1357, 1241, 1221, 907, 818, 737, 654, 424 cmÀ1; HRMS
(ESI): m/z: calcd for C20H16ClNNaO2: 360.0767 [M+Na]+; found:
360.0755.
425 cmÀ1
; HRMS (ESI): m/z: calcd for C21H19NNaO3: 356.1263
[M+Na]+; found: 356.1255.
1-[6-Chloro-2-methyl-4-(2-methyl-1H-indol-3-yl)-4H-chromen-3-
yl]ethanone (3h): Brown liquid; 1H NMR (400 MHz, CDCl3, 258C,
TMS): d=2.09 (s, 3H), 2.30 (s, 3H), 2.37 (s, 3H), 5.32 (s, 1H), 6.90–
6.95 (m, 2H), 7.00–7.08 (m, 3H), 7.17 (d, J=7.6 Hz, 1H), 7.46 (d, J=
7.6 Hz, 1H), 8.09 ppm (s, 1H); 13C NMR (100 MHz, CDCl3): d=11.8,
19.5, 29.7, 31.8, 110.4, 112.9, 115.5, 117.3, 117.5, 119.7, 121.1, 127.2,
127.5, 128.8, 128.8, 131.8, 134.9, 147.5, 156.4, 199.9 ppm; IR: n˜ =
3395, 3058, 2922, 2247, 1879, 1679, 1619, 1573, 1479, 1225, 907,
817, 735, 652, 428 cmÀ1; HRMS (ESI): m/z: calcd for C21H18ClNNaO2:
374.0924 [M+Na]+; found: 374.0910.
1-[4-(1H-Indol-3-yl)-2,6,8-trimethyl-4H-chromen-3-yl]ethanone
1
(3n): Brown liquid; H NMR (400 MHz, CDCl3, 258C, TMS): d=2.01
(s, 3H), 2.14 (s, 3H), 2.27 (s, 3H), 2.47 (s, 3H), 5.26 (s, 1H), 6.74 (s,
1H), 6.86–6.90 (m, 2H), 7.10–7.13 (m, 2H), 7.22–7.23 (m, 1H), 7.70–
7.71 (m, 1H), 8.28 ppm (s, 1H); 13C NMR (100 MHz, CDCl3): d=15.2,
19.6, 20.2, 29.1, 32.8, 110.9, 113.3, 118.3, 119.3, 121.2, 121.5, 122.1,
124.1, 124.6, 125.3, 125.9, 132.6, 136.0, 145.0, 158.1, 199.5 ppm; IR:
n˜ =3411, 3347, 2921, 2247, 1675, 1584, 1482, 1378, 1212, 1150,
932, 909, 739, 652, 552, 423 cmÀ1; HRMS (ESI): m/z: calcd for
C22H21NNaO2: 354.1470 [M+Na]+; found: 354.1462.
1-[4-(1H-Indol-3-yl)-2-methyl-4H-chromen-3-yl]ethanone
(3i):
1
Brown liquid; H NMR (400 MHz, CDCl3, 258C, TMS): d=2.11 (s, 3H),
2.43 (s, 3H), 5.30 (s, 1H), 6.82 (d, J=2.4 Hz, 1H), 6.87 (t, 1H), 6.98
(d, J=8.0 Hz, 1H), 7.04 (d, J=7.6 Hz, 1H), 7.09–7.11 (m, 2H), 7.19 (t,
2H), 7.67–7.69 (t, 1H), 8.34 ppm (s, 1H); 13C NMR (100 MHz, CDCl3):
d=19.8, 29.4, 32.9, 111.4, 113.7, 116.0, 118.5, 119.6, 121.1, 121.9,
122.6, 124.2, 125.1, 125.6, 127.3, 128.7, 136.4, 148.9, 158.0,
200.1 ppm; IR: n˜ =3408, 3057, 2924, 2247, 1798, 1675, 1619, 1574,
1486, 1378, 1218, 939, 908, 739, 647, 597, 425 cmÀ1; HRMS (ESI):
m/z: calcd for C20H17NNaO2: 326.1157 [M+Na]+; found: 326.1154.
4-(3-Acetyl-6-bromo-2-methyl-4H-chromen-4-yl)-5-methyl-2-
phenyl-1H-pyrazol-3(2H)one (5a): Yellow liquid; 1H NMR
(400 MHz, CDCl3, 258C, TMS): d=2.11 (s, 3H), 2.31 (s, 3H), 2.36 (s,
3H), 3.01 (s, 3H), 5.16 (s, 1H), 6.86 (d, J=8.0 Hz, 1H), 7.23–7.28 (m,
2H), 7.36 (d, J=6.4 Hz, 3H), 7.43 ppm (t, J=8.0 Hz, 2H); 13C NMR
(100 MHz, CDCl3): d=10.7, 19.5, 29.6, 29.7, 35.4, 111.6, 113.5, 116.6,
117.6, 123.9, 125.3, 126.5, 129.1, 130.7, 131.5, 134.7, 148.4, 153.4,
157.8, 164.4, 199.6 ppm; IR: n˜ =3062, 2923, 2240, 1733, 1660, 1478,
1239, 940, 730, 648, 591, 500 cmÀ1; HRMS (ESI): m/z: calcd for
C23H21BrN2NaO3: 475.0633 [M+Na]+; found: 475.0619.
1-[4-(1H-Indol-3-yl)-6-methoxy-2-methyl-4H-chromen-3-yl]etha-
1
none (3j): Brown liquid; H NMR (400 MHz, CDCl3, 258C, TMS): d=
Ethyl 2-acetyl-5,5-bis(5-bromo-1H-indol-3-yl)pentanoate (7c):
1
2.14 (s, 3H), 2.44 (s, 3H), 3.60 (s, 3H), 5.29 (s, 1H), 6.62–6.65 (m,
1H), 6.74–6.75 (m, 1H), 6.91–6.94 (m, 2H), 7.09–7.13 (m, 2H), 7.22–
7.25 (m, 1H), 7.67–7.69 (m, 1H), 8.37 ppm (s, 1H); 13C NMR
(100 MHz, CDCl3): d=19.9, 29.5, 33.4, 55.3, 111.3, 112.8, 113.0, 113.1,
116.8, 118.5, 119.7, 121.0, 122.0, 122.4, 125.6, 125.8, 136.4, 143.1,
155.9, 158.4, 199.7 ppm; IR: n˜ =3409, 3349, 3057, 2930, 2836, 2248,
Brown liquid; H NMR (400 MHz, CDCl3, 258C, TMS): d=1.20 (t, J=
7.2 Hz, 3H), 1.84–1.96 (m, 2H), 2.06–2.12 (m, 2H), 2.14 (s, 3H), 3.47
(t, J=6.0 Hz, 1H), 4.15 (dd, Ja =7.2, Jb =14.4 Hz, 2H), 4.27 (t, J=
7.2 Hz, 1H), 6.86 (d, J=6.8 Hz, 2H), 7.12 (dd, Ja =8.8, Jb =26.0 Hz,
4H), 7.60 (s, 2H), 8.22 ppm (s, 2H); 13C NMR (100 MHz, CDCl3): d=
14.0, 26.6, 28.9, 32.5, 33.7, 59.5, 61.5, 112.1, 112.8, 118.0, 118.2,
121.6, 122.9, 124.5, 128.2, 128.2, 135.1, 169.8, 203.8 ppm; IR n˜ =
3421, 3076, 2981, 2933, 2251, 1855, 1731, 1708, 1559, 1459, 1214,
1097, 909, 884, 796, 732, 585, 422 cmÀ1; HRMS (ESI): m/z: calcd for
C25H24Br2N2NaO3: 581.0051 [M+Na]+; found: 581.0032.
1675, 1582, 1495, 1427, 1215, 1036, 928, 742, 640, 601, 424 cmÀ1
;
HRMS (ESI): m/z: calcd for C21H19NNaO3: 356.1263 [M+Na]+; found:
356.1255.
1-[6-(tert-Butyl)-4-(1H-indol-3-yl)-2-methyl-4H-chromen-3-yl]e-
1
thanone (3k): Brown liquid; H NMR (400 MHz, CDCl3, 258C, TMS):
Methyl 2-acetyl-5,5-bis(2-methyl-1H-indol-3-yl)pentanoate (7d):
Brown liquid; 1H NMR (400 MHz, CDCl3, 258C, TMS): d=1.88–1.96
(m, 2H), 2.08 (s, 3H), 2.20 (d, J=2.4 Hz, 6H), 2.36–2.43 (m, 2H),
3.45 (t, J=7.6 Hz, 1H), 3.64 (s, 3H), 4.38 (t, J=8.0 Hz, 1H), 6.95–
7.04 (m, 4H), 7.14 (d, J=8.0 Hz, 2H), 7.59 (dd, Ja =7.2, Jb =8.0 Hz,
2H), 7.74 ppm (s, 2H); 13C NMR (100 MHz, CDCl3): d=12.5, 12.5,
d=1.16 (s, 9H), 2.15 (s, 3H), 2.45 (s, 3H), 5.31 (s, 1H), 6.86 (d, J=
2.8 Hz, 1H), 6.93 (d, J=8.4 Hz, 1H), 7.10–7.13 (m, 3H), 7.19–7.22
(m, 1H), 7.32 (d, J=2.0 Hz, 1H), 7.75–7.77 (m, 1H), 8.34 ppm (s,
1H); 13C NMR (100 MHz, CDCl3): d=19.9, 29.4, 31.2, 33.5, 34.1,
111.3, 113.6, 115.6, 118.7, 119.5, 121.1, 121.9, 122.4, 124.4, 125.2,
Chem. Eur. J. 2014, 20, 549 – 558
556
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim